全文获取类型
收费全文 | 2030篇 |
免费 | 101篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 62篇 |
妇产科学 | 7篇 |
基础医学 | 223篇 |
口腔科学 | 50篇 |
临床医学 | 140篇 |
内科学 | 543篇 |
皮肤病学 | 52篇 |
神经病学 | 193篇 |
特种医学 | 61篇 |
外科学 | 410篇 |
综合类 | 9篇 |
预防医学 | 41篇 |
眼科学 | 20篇 |
药学 | 121篇 |
中国医学 | 3篇 |
肿瘤学 | 136篇 |
出版年
2023年 | 8篇 |
2022年 | 33篇 |
2021年 | 36篇 |
2020年 | 16篇 |
2019年 | 44篇 |
2018年 | 47篇 |
2017年 | 41篇 |
2016年 | 41篇 |
2015年 | 39篇 |
2014年 | 51篇 |
2013年 | 55篇 |
2012年 | 93篇 |
2011年 | 116篇 |
2010年 | 58篇 |
2009年 | 73篇 |
2008年 | 92篇 |
2007年 | 105篇 |
2006年 | 116篇 |
2005年 | 125篇 |
2004年 | 123篇 |
2003年 | 98篇 |
2002年 | 120篇 |
2001年 | 70篇 |
2000年 | 69篇 |
1999年 | 62篇 |
1998年 | 28篇 |
1997年 | 20篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 16篇 |
1993年 | 10篇 |
1992年 | 38篇 |
1991年 | 29篇 |
1990年 | 21篇 |
1989年 | 20篇 |
1988年 | 23篇 |
1987年 | 24篇 |
1986年 | 14篇 |
1985年 | 9篇 |
1982年 | 6篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 9篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1972年 | 10篇 |
1971年 | 6篇 |
1969年 | 10篇 |
1968年 | 7篇 |
1967年 | 8篇 |
排序方式: 共有2146条查询结果,搜索用时 0 毫秒
71.
72.
73.
Muhle ML Stammers AH Tremain KD Niimi KS Glogowski KR Trowbridge CC Yang T 《Perfusion》2001,16(4):293-299
A common anesthetic technique utilized during cardiopulmonary bypass (CPB) includes the use of various inhalation agents, such as isoflurane. The purpose of this study was to evaluate the effects of this agent on oxygen transfer during CPB. An in vitro model was designed using bovine blood. Blood flow was held constant at 2 l/min, while gas flow was manipulated at 1 and 3 l/min. The percentage of inspired oxygen (FiO2) was set at 50 and 100%, and isoflurane was manipulated to 1.0, 3.0 and 5.0%. Blood gas analysis, oxygen transfer, and inlet and outlet isoflurane concentrations were measured at each of the given conditions. A total of 12 trials with four oxygenators were conducted. In the four oxygenators used in our study, no significant differences in oxygenator performance were found. At conditions of 1 I/min gas flow, 50% FiO2 and 1% isoflurane, there were no significant changes in O2 transfer between baseline and measurements taken during isoflurane administration (100.18 +/- 12.49 vs 102.35 +/- 10.99 ml O2/min, p=0.8031). At 3 I/min gas flow, 100% FiO2 and 5% isoflurane, no significant differences were found (142.35 +/- 10.76 vs 154.04 +/- 8.95 ml O2/min, p=0.1459). The only significant differences found for oxygen transfer were between 50 and 100% FiO2, all other conditions being set equal (102.35 +/- 10.99 vs 137.68 +/- 8.62 ml O2/min, p=0.0023). In conclusion, increasing concentrations of isoflurane up to 5% does not affect the efficiency of oxygen transfer in an in vitro circuit. Further studies are necessary to evaluate the effects in an in vivo setting. 相似文献
74.
75.
Takahashi K Chin K Akamizu T Morita S Sumi K Oga T Matsumoto H Niimi A Tsuboi T Fukuhara S Kangawa K Mishima M 《Respirology (Carlton, Vic.)》2008,13(6):810-816
Background and objective: Patients with newly diagnosed OSA have been reported to have recent weight gain prior to diagnosis. Ghrelin stimulates food intake and increases weight gain. Plasma ghrelin is decreased in obese and increased in lean individuals. Of the two circulating forms of ghrelin, acylated and unacylated, the former is thought to be essential for the biological activity of ghrelin. Methods: The plasma levels of the two forms of ghrelin were measured in 21 OSA patients (with a mean of 46.2 sleep‐disordered events/h) before and after 1 month of nasal CPAP (nCPAP) treatment, and were compared with those in 14 untreated OSA patients and 13 individuals without OSA. Results: The BMI was significantly higher in the 21 OSA patients than in the non‐OSA group as were the baseline acylated (11.4 ± 5.86 vs 7.19 ± 3.80 fmol/mL, P = 0.03) and unacylated (84.2 ± 50.6 vs 48.3 ± 23.2 fmol/mL, P = 0.02) ghrelin levels. The total ghrelin level was positively correlated with the number of sleep‐disordered breathings (P = 0.002). After 1 month of nCPAP treatment, the acylated ghrelin level significantly decreased (P = 0.02) while the unacylated ghrelin level did not (P = 0.09). Conclusions: Treatment of OSA may play an important role in the management of obesity in these patients by reducing the acylated ghrelin level. 相似文献
76.
Zi-chen CHEN Yu-zhong ZHANG Huan-di ZHAO Xinyu WEI Toshihisa Murofushi Juan HU Ying CHENG Fei-yun CHEN Xin-da XU Min XU Qing ZHANG 《华中科技大学学报(医学英德文版)》2021,(4):695-704
Objective:Auditory neuropathy(AN)is a unique pattern of hearing loss with preservation of hair cell function.The condition is characterized by the presence of o... 相似文献
77.
Akitoshi Hakoda Toshihisa Takeuchi Yuichi Kojima Yasuhiro Fujiwara Yasuaki Nagami Yuji Naito Shinsaku Fukuda Tomoyuki Koike Mitsushige Sugimoto Kenta Hamada Hideki Kobara Norimasa Yoshida Tomoki Inaba Akihito Nagahara Eriko Koizumi Kazunari Murakami Takahisa Furuta Naotaka Ogasawara Hajime Isomoto Kotaro Shibagaki Hiromi Kataoka Hidekazu Suzuki Kazuhide Higuchi 《Journal of Clinical Biochemistry and Nutrition》2022,70(2):189
Bleeding after gastric endoscopic submucosal dissection (ESD) remains problematic, especially in patients receiving antithrombotic therapy. Therefore, this study aimed to identify the risk factors. In this retrospective study, patients (n = 1,207) who underwent gastric ESD while receiving antithrombotic therapy were enrolled at Osaka Medical and Pharmaceutical University Hospital and 18 other referral hospitals in Japan. Risks of post-ESD bleeding were calculated using multivariable logistic regression. The dataset was divided into a derivation cohort and a validation cohort. We created a prediction model using the derivation cohort. The accuracy of the model was evaluated using the validation cohort. Post-ESD bleeding occurred in 142 (11.8%) participants. Multivariable analysis yielded an odds ratio of 2.33 for aspirin, 4.90 for P2Y12 receptor antagonist, 1.79 for cilostazol, 0.95 for other antithrombotic agents, 6.53 for warfarin, 5.65 for dabigatran, 7.84 for apixaban, 10.45 for edoxaban, 6.02 for rivaroxaban, and 1.46 for heparin bridging. The created prediction model was called safe ESD management using the risk analysis of post-bleeding in patients with antithrombotic therapy (SAMURAI). This model had good predictability, with a C-statistic of 0.77. In conclusion, use of the SAMURAI model will allow proactive management of post-ESD bleeding risk in patients receiving antithrombotic therapy. 相似文献
78.
Kumamoto Y Tsukamoto T Matsukawa M Kunishima Y Watanabe K Kobayashi Y Uchida H Matsuda S Hirose T Sato S Shigeta S Fujime M Fujita K Yamaguti O Ishibashi K Igari J Suzutani T Oguri T Yoshida H Imafuku Y Yamaguchi K Furuya N Murai M Deguchi T Ishihara S Ooe H Matsumoto T Takahashi K Nishikawa M Naito S Egashira T Konishi T Oka T Kitamura M Kohno S Fukuhara Y Hirakata Y Kondo A Matsuda J Nakano M Kamidono S Suzuki Y Arakawa S Kumon H Monden K 《The Japanese journal of antibiotics》2005,58(6):518-543
The bacterial strains isolated from 565 patients diagnosed as having urinary tract infections (UTIs) in 14 institutions in Japan were collected between August 2003 and July 2004. The susceptibilities of them to many kinds of antimicrobial agents were investigated. Of them, 701 strains were estimated as prophlogistic bacteria and used for the investigation. The strains consisted of 258 Gram-positive bacterial strains (36.8%) and 443 Gram-negative bacterial strains (63.2%). Against Staphylococcus aureus, vancomycin (VCM) showed the strongest activity and prevented the growth of all strains with 2 microg/mL. Against Streptococcus agalactiae, ampicillin (ABPC), cefozopran (CZOP), imipenem (IPM), and clarithromycin (CAM) showed a strong activity and the MIC90 was 0.125 microg/mL or less. Against Enterococcus faecalis, VCM, ABPC, and IPM showed a strong antibacterial activity. The antibacterial activity of cephems to Escherichia coli was generally good, and especially CZOP and cefpirome (CPR) showed the strongest activity (MIC90: < or = 0.125 microg/mL). Quinolone resistant E. coli [MIC of ciprofloxacin (CPFX): > or =4 microg/mL] was detected at frequency of 15.7%, which was higher than that in the last year. Against Klebsiella pneumoniae, meropenem (MEPM) showed the strongest activity and next, the antibacterial activity of CRMN and CZOP was good. The antibacterial activity of the other cephems, however, significantly decreased, compared with that evaluated in last year. Against Serratia marcescens, MEPM had the strongest antibacterial activity. Against Proteus mirabilis, MEPM and CRMN showed the strongest activity and prevented the growth of all strains with 0.125 microg/mL or less. Nest, cefmenoxime (CMX), ceftazidime (CAZ), cefixime (CFIX), cefpodoxime (CPDX), CPR, CZOP, and cefditoren (CDTR) showed a strong activity. The antibacterial activity of the drugs to Pseudomonas aeruginosa was generally low, and MIC90 of all the drugs was ranged from 32 to < or = 256 microg/mL except IPM and amikacin (AMK) having 16 microg/mL. The antibacterial activity of CZOP was relatively good (MIC50: 2 microg/mL). 相似文献
79.
Josefine Hirschfeld Mohammed Howait Alexandru Movila Marijo Parčina Isabelle Bekeredjian‐Ding James Deschner Søren Jepsen Toshihisa Kawai 《European journal of oral sciences》2017,125(5):345-354
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine and counter‐regulator of endogenous glucocorticoids (GCs). It is implicated in acute and chronic inflammatory diseases. This study investigated the role of the MIF–GC regulatory dyad in the expression and release of matrix metalloproteinase‐2 (MMP‐2) during periodontitis, in vivo and in vitro. In a Mif‐knockout (KO) mouse model of ligature‐induced periodontitis, gingival tissues and blood were collected and analysed for levels of interleukin‐6 (IL‐6), MIF, MMP‐2, and corticosterone. In addition, human gingival fibroblasts (HGFs) were tested for production of IL‐6 and MMP‐2 after stimulation with hydrocortisone (HC), MIF, tumour necrosis factor‐alpha (TNF‐α), or Fusobacterium nucleatum, a pathogen known to elicit immune responses during periodontitis. Wild‐type (WT) mice showed a local and systemic increase of MIF levels during inflammation, which was confirmed by increased local IL‐6 concentrations. Systemic GC levels were reduced in WT and Mif‐KO mice during inflammation, with overall lower concentrations in Mif‐KO mice. In vivo and in vitro, MMP‐2 production was not dependent on MIF or inflammatory stimuli, but was inhibited by HC. Therefore, MIF does not appear to stimulate expression of MMP‐2 in the gingival tissues, whereas GC upregulates MIF and downregulates MMP‐2. Our findings further suggest that MIF may regulate systemic GC levels. 相似文献
80.
Masakazu Niimi Norman A. Firth Richard D. Cannon 《Odontology / the Society of the Nippon Dental University》2010,98(1):15-25
Fungi comprise a minor component of the oral microbiota but give rise to oral disease in a significant proportion of the population.
The most common form of oral fungal disease is oral candidiasis, which has a number of presentations. The mainstay for the
treatment of oral candidiasis is the use of polyenes, such as nystatin and amphotericin B, and azoles including miconazole,
fluconazole, and itraconazole. Resistance of fungi to polyenes is rare, but some Candida species, such as Candida glabrata and C. krusei, are innately less susceptible to azoles, and C. albicans can acquire azole resistance. The main mechanism of high-level fungal azole resistance, measured in vitro, is energy-dependent
drug efflux. Most fungi in the oral cavity, however, are present in multispecies biofilms that typically demonstrate an antifungal
resistance phenotype. This resistance is the result of multiple factors including the expression of efflux pumps in the fungal
cell membrane, biofilm matrix permeability, and a stress response in the fungal cell. Removal of dental biofilms, or treatments
to prevent biofilm development in combination with antifungal drugs, may enable better treatment and prevention of oral fungal
disease. 相似文献